Children living with sickle cell can be treated safely using hydroxyurea, 10-year trial finds
New research shows the efficacy and safety of hydroxyurea treatment for sickle cell anemia at four low-income sites in Africa, with no increase in clinically diagnosed infections.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Protein LMOD1 offers new clues to muscle regeneration
United Kingdom
-
Fruit fly study reveals how neural gates switch on short-term memory
United Kingdom
-
Intranasal sufentanil-ketamine appears safe, effective for pediatric acute pain
United Kingdom
-
Global study finds stark differences in maternal RSV vaccine uptake
United Kingdom
-
HPV vaccination before pregnancy linked to lower risk of preterm birth and other major complications
United Kingdom
-
NHS labs fail to share data vital for diagnosis and care of rare diseases, investigation finds
United Kingdom
-
About 13% of newly qualified nurses and midwives leave hospital work within six years
United Kingdom
-
New guidance outlines how to protect people living with heart disease during heat waves
United Kingdom